These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 622235

  • 1. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
    Notation AD, Tagatz GE, Steffes MW.
    Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
    [Abstract] [Full Text] [Related]

  • 2. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
    Tanaka T, Sakuragi N, Fujimoto S, Ichinoe K.
    Int J Fertil; 1982 Feb; 27(2):100-4. PubMed ID: 6126442
    [Abstract] [Full Text] [Related]

  • 3. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH.
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [Abstract] [Full Text] [Related]

  • 4. Ovulation monitored by serum 17 beta-estradiol and ultrasound: differential ovarian response to human gonadotropins in various anovulatory states.
    Padova G, Briguglia G, Tita P, Arpi ML, Munguira ME, Cafiso F, Cianci A, Ettore G, Pezzino V.
    Acta Eur Fertil; 1988 Mar; 19(5):283-6. PubMed ID: 3150888
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT, Ohlinger R.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):87-92. PubMed ID: 16377065
    [Abstract] [Full Text] [Related]

  • 6. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
    Muechler EK, Kohler D, Huang KE.
    Int J Fertil; 1981 May 01; 26(4):273-8. PubMed ID: 6120908
    [Abstract] [Full Text] [Related]

  • 7. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S, Paradisi R, Fabbri R, Porcu E, Orsini LF, Flamigni C.
    Int J Fertil; 1987 May 01; 32(1):66-70. PubMed ID: 2880819
    [Abstract] [Full Text] [Related]

  • 8. Pre-ovulatory plasma levels of 17beta-oestradiol (E2) and conception in patients treated with gonadotrophins.
    Ferin J, Thomas K, De Hertogh R.
    Acta Endocrinol Suppl (Copenh); 1977 May 01; 214():33-42. PubMed ID: 268747
    [Abstract] [Full Text] [Related]

  • 9. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z, Lang N, Amit A, Kahana L, Yoffe N.
    Fertil Steril; 1994 Sep 01; 62(3):456-60. PubMed ID: 8062938
    [Abstract] [Full Text] [Related]

  • 10. [The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
    Kooguchi J, Uemura T, Shiojima Y, Iwasaki H.
    Acta Obstet Gynaecol Jpn; 1981 Jun 01; 33(6):777-85. PubMed ID: 6787830
    [Abstract] [Full Text] [Related]

  • 11. Ovulation induction with gonadotropins in women with polycystic ovary disease.
    Kupferminc MJ, Lessing JB, Peyser MR.
    J Reprod Med; 1991 Jan 01; 36(1):61-4. PubMed ID: 1901089
    [Abstract] [Full Text] [Related]

  • 12. Ovulation induction with human menopausal gonadotropins.
    Diamond MP, Wentz AC.
    Obstet Gynecol Surv; 1986 Aug 01; 41(8):480-90. PubMed ID: 3090489
    [Abstract] [Full Text] [Related]

  • 13. Induction of ovulation and pregnancy in twenty-six patients with primary hypogonadotropic amenorrhea.
    Batrinos ML, Panitsa-Faflia C.
    Int J Fertil; 1980 Aug 01; 25(4):257-66. PubMed ID: 6114047
    [Abstract] [Full Text] [Related]

  • 14. Restoration of the ovarian response to gonadotropins in patients after molar abortion.
    Miyake A, Aono T, Kurachi H, Tsutsumi H, Kurachi K.
    Obstet Gynecol; 1981 Nov 01; 58(5):566-8. PubMed ID: 6795552
    [Abstract] [Full Text] [Related]

  • 15. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A, David H, Libal Y, Ballas S.
    Harefuah; 1995 Dec 01; 129(11):455-6, 536. PubMed ID: 8846950
    [Abstract] [Full Text] [Related]

  • 16. Influence of serum progesterone levels at the time of hCG on the release of ova during hMG cycles.
    Check JH, Adelson HG, Stern J, Lauer C.
    Int J Fertil; 1992 Dec 01; 37(2):103-5. PubMed ID: 1349590
    [Abstract] [Full Text] [Related]

  • 17. [Critical evaluation of clinical and hormonal parameters for the optimal timing of induction of ovulation with gonadotropins (author's transl)].
    Hardt W, Schmidt-Gollwitzer M, Boquol E, Stadler C, Nevinny-Stickel J.
    Geburtshilfe Frauenheilkd; 1977 Nov 01; 37(11):925-33. PubMed ID: 924102
    [Abstract] [Full Text] [Related]

  • 18. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM, Tomazevic T.
    J Reprod Med; 1995 Jan 01; 40(1):37-40. PubMed ID: 7722973
    [Abstract] [Full Text] [Related]

  • 19. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
    Olson JL, Rebar RW, Schreiber JR, Vaitukaitis JL.
    Fertil Steril; 1983 Mar 01; 39(3):284-91. PubMed ID: 6402386
    [Abstract] [Full Text] [Related]

  • 20. [Endocrine evaluation of induction of ovulation with pulsatile and continuous administration of human menopausal gonadotropin (hMG) in anovulatory women].
    Masaoka K, Kitazawa M, Niibe T, Kumasaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan 01; 38(1):73-80. PubMed ID: 3081669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.